277 related articles for article (PubMed ID: 20465393)
1. Mechanism of lymph node metastasis in prostate cancer.
Datta K; Muders M; Zhang H; Tindall DJ
Future Oncol; 2010 May; 6(5):823-36. PubMed ID: 20465393
[TBL] [Abstract][Full Text] [Related]
2. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic vessel activation in cancer.
Das S; Skobe M
Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
[TBL] [Abstract][Full Text] [Related]
5. The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.
Bolenz C; Fernández MI; Tilki D; Herrmann E; Heinzelbecker J; Ergün S; Ströbel P; Reich O; Michel MS; Trojan L
BJU Int; 2009 Sep; 104(5):592-7. PubMed ID: 19594740
[TBL] [Abstract][Full Text] [Related]
6. Risk of prostate carcinoma death in patients with lymph node metastasis.
Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
[TBL] [Abstract][Full Text] [Related]
7. PKCζ facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model.
Zang G; Mu Y; Gao L; Bergh A; Landström M
Oncogene; 2019 May; 38(22):4215-4231. PubMed ID: 30705401
[TBL] [Abstract][Full Text] [Related]
8. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L
Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Hou Q; Chen S; An Q; Li B; Fu Y; Luo Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299365
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.
Boormans JL; Wildhagen MF; Bangma CH; Verhagen PC; van Leenders GJ
BJU Int; 2008 Dec; 102(11):1589-93. PubMed ID: 18710447
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment on "Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer".
Janetschek G; Hruby S
Scand J Urol; 2015 Feb; 49(1):77-8. PubMed ID: 25363609
[No Abstract] [Full Text] [Related]
12. The expression of p-mTOR and COUP-TFII correlates with increased lymphangiogenesis and lymph node metastasis in prostate adenocarcinoma.
Lilis I; Giopanou I; Papadaki H; Gyftopoulos K
Urol Oncol; 2018 Jun; 36(6):311.e27-311.e35. PubMed ID: 29544697
[TBL] [Abstract][Full Text] [Related]
13. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein inhibits lymphangiogenesis and resultant lymph node metastasis of squamous cell carcinoma in mice.
Sasaki T; Motoyama S; Sato Y; Yoshino K; Matsumoto G; Minamiya Y; Saito H; Murata K; Ogawa J
Surgery; 2013 Nov; 154(5):1087-92. PubMed ID: 23859309
[TBL] [Abstract][Full Text] [Related]
16. Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome.
Adams J; Cheng L
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1457-69. PubMed ID: 21929319
[TBL] [Abstract][Full Text] [Related]
17. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ
BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398
[TBL] [Abstract][Full Text] [Related]
18. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral Cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract][Full Text] [Related]
19. Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients.
Chen Z; Wang T; Luo H; Lai Y; Yang X; Li F; Lei Y; Su C; Zhang X; Lahn BT; Xiang AP
Hum Pathol; 2010 May; 41(5):737-44. PubMed ID: 20132963
[TBL] [Abstract][Full Text] [Related]
20. Twist modulates lymphangiogenesis and correlates with lymph node metastasis in supraglottic carcinoma.
Lu SM; Yu L; Tian JJ; Ma JK; Li JF; Xu W; Wang HB
Chin Med J (Engl); 2011 May; 124(10):1483-7. PubMed ID: 21740802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
